Acne

Researchers, along with the American Academy of Dermatology, have organized an iPLEDGE Workgroup to advocate for its reform with the goal of reducing administrative burden.

CHICAGO — It is important for clinicians to realize that there are many barriers to a person’s gender transition, Jennifer L. MacGregor, MD, said here at the American Society for Dermatologic Surgery annual meeting.

Be sure to check out Healio Dermatology’s live coverage from the American Society for Dermatologic Surgery annual meeting.

CHICAGO — Combining the use of gold microparticles with laser-mediated photothermolysis and topical retinoids was associated with a 61% reduction in inflammatory lesion count at 3 months among patients with mild to moderate acne vulgaris, according to data presented at the American Society for Dermatologic Surgery annual meeting.

CHICAGO — Initial data presented here by Mark S. Nestor, MD, PhD, showed a decrease in the number of active acne lesions on the back 3 months after a single nano-pulse stimulation treatment.

The FDA has approved Amzeeq topical foam 4% for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older.

Among topical dermatologic drugs, the mean overpayment for brand-name drugs was more than double that of generics, based on an analysis of claims data of privately insured individuals published in JAMA Dermatology.

The FDA recently approved Galderma’s topical retinoid cream, known as Aklief, for the treatment of acne vulgaris.

Patients with lupus should avoid combined oral contraceptive pills and tetracycline-class medications for acne, whereas isotretinoin and spironolactone may be considered safe treatment options, according to a systematic review.

In alopecia areata, combination tofacitinib and oral minoxidil therapy may be superior to tofacitinib alone, according to researchers from Yale University School of Medicine, in the top Healio Dermatology story from last week.